Our cost analysis confirms this potential by demonstrating a savings of $49.87 per ASCUS case, $156.81 per LSIL case, and $162.16 per ASC-H case. There are obviously several assumptions that must ...
Background: The diagnosis of atypical squamous cells of undetermined significance (ASCUS) during cervical screening indicates cellular abnormality but is not sufficient for a definitive diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback